Related Experiment Video
Updated: Feb 17, 2026

07:57
An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices
Published on: April 11, 2018
7.4K
Alzheimer disease neuropathology: understanding autonomic dysfunction
Eliasz Engelhardt1, Jerson Laks2
1MD, PhD, Coordinator of the Cognitive and Behavioral Unit - INDC-UFRJ.
Dementia & Neuropsychologia
|December 8, 2017
Summary
Alzheimer's disease (AD) neuropathology affects autonomic nervous system structures, leading to autonomic dysfunction. This dysfunction may increase morbidity and mortality in AD patients, necessitating clinical consideration.
Area of Science:
- Neuropathology
- Neurodegenerative Diseases
- Autonomic Nervous System
Background:
- Alzheimer's disease (AD) research traditionally focuses on cognitive and behavioral symptoms, with less attention to autonomic dysfunctions.
- Autonomic dysfunctions in AD are significant, potentially increasing morbidity and mortality.
- The neuropathological impact of AD on autonomic structures remains understudied.
Purpose of the Study:
- To review the neurodegenerative processes in Alzheimer's disease affecting central autonomic-related regions.
- To analyze cortical, subcortical, and caudal autonomic structures impacted by AD.
Main Methods:
- Comprehensive literature search of MedLine, PsycInfo, and Lilacs databases.
- Inclusion of bibliographical references and manual searches of classic studies.
- Review spanned over a century of AD and autonomic nervous system research.
Main Results:
- Central autonomic structures include cortical and subcortical areas (amygdala, thalamus, hypothalamus, brainstem, cerebellum) and the spinal cord.
- These structures form vital autonomic neural networks.
- Alzheimer's disease neurodegeneration progressively affects these autonomic structures according to Braak staging.
Conclusions:
- Damage to central autonomic neural networks by progressive neurodegeneration is the neuropathological basis of autonomic dysfunction in AD.
- Autonomic dysfunction in AD patients is linked to increased morbidity and potentially mortality.
- Clinicians should consider autonomic dysfunction in the management of Alzheimer's disease patients.
Related Concept Videos
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Disorders of the Autonomic Nervous System
1.6K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.6K
Neural Regulation
43.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.5K
Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Alzheimer's Disease: Treatment
1.0K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.0K
Disorders of the Nervous Tissue
2.7K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.7K

